Evaluation of novel Anti-SARS-CoV-2 compounds by targeting nucleoprotein and envelope protein through homology modeling, docking simulations, ADMET, and molecular dynamic simulations with the MM/GBSA calculation
2024Intelligent PharmacyJournalOpen access
10.1016/j.ipha.2024.02.008Full text10 citations